PRESS RELEASE published on 01/30/2026 at 07:57, 9 months 1 day ago Informations privilégiées / Autres communiqués Le Tribunal des activités économiques de Lyon valide le plan de continuation de POXEL SA, une société biopharmaceutique en phase clinique, mettant fin à la procédure de redressement judiciaire Plan De Continuation Redressement Judiciaire Validation Poxel SA Tribunal De Lyon
PRESS RELEASE published on 01/30/2026 at 07:57, 9 months 1 day ago Inside Information / Other news releases Poxel SA receives approval for recovery plan from Commercial Court of Lyon, closing reorganisation proceedings and focusing on business development, cost optimization, settlement of liabilities, and financial strengthening Business Development Recovery Plan Financial Restructuring Poxel SA Commercial Court Of Lyon
BRIEF published on 12/11/2025 at 19:47, 10 months 19 days ago Résultats de l'Assemblée Générale de Poxel SA Actionnaires Plan De Redressement Société Biopharmaceutique Résultats Votes Assemblée Générale Poxel
BRIEF published on 12/11/2025 at 19:47, 10 months 19 days ago Poxel Reports Outcomes of General Meeting and Looks Ahead Shareholders General Meeting Biopharmaceutical Recovery Plan Poxel
BRIEF published on 12/11/2025 at 19:47, 10 months 19 days ago Poxel publie les résultats de son assemblée générale et ses perspectives d'avenir Actionnaires Assemblée Générale Biopharmaceutique Poxel Plan De Rétablissement
BRIEF published on 12/11/2025 at 19:47, 10 months 19 days ago Results of the General Meeting of Poxel SA Shareholders Biopharmaceutical Company Recovery Plan Vote Results Poxel General Assembly
PRESS RELEASE published on 12/11/2025 at 19:42, 10 months 19 days ago Inside Information / Other news releases Poxel announces successful results of its Combined General Meeting on December 11, 2025, with a 36.123% quorum. Key step ahead in January 2026 at Lyon Economic Court Recovery Plan Quorum Combined General Meeting Results Poxel
PRESS RELEASE published on 12/11/2025 at 19:42, 10 months 19 days ago Informations privilégiées / Autres communiqués Poxel annonce les résultats de son Assemblée Générale Mixte du 11 décembre 2025. Prochaine étape : validation du plan de redressement en janvier 2026 Assemblée Générale Résultats Biopharmaceutique Plan De Redressement Poxel
BRIEF published on 12/10/2025 at 08:57, 10 months 21 days ago Poxel's Financial Results and Governance Changes in H1 2025 Strategic Partnerships Revenue Growth Governance Changes Receivership Proceedings Poxel Financial Results
BRIEF published on 12/10/2025 at 08:57, 10 months 21 days ago Résultats semestriels et défis de Poxel au premier semestre 2025 Chiffre D'affaires Résultats Financiers Stratégie Commerciale Redressement Judiciaire Poxel
Published on 10/30/2026 at 23:35, 16 hours 7 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 16 hours 12 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 18 hours 55 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 20 hours 42 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 16 hours 53 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 21 hours 4 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 16 hours 42 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 16 hours 42 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
